Hosted on MSN

FDA Announces Groundbreaking Shift: Replacing Animal Testing With Advanced Human-Relevant Methods For Drug Development

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a new initiative to significantly reduce, refine, and replace animal testing ...

A miniature human liver transforms toxicology testing of food contaminants

Assessing the toxicity of food contaminants—including carcinogenic potential—is a major challenge in evaluating the risks ...
Radio Prague International

‘No more animal testing’: Scientists in Zlín developing lab model of the human small intestine

Scientists in Zlín are developing an advanced model of the human small intestine. The main goal behind this effort is to ...
Business Wire

Vivodyne Announces $38 Million Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human Organs

PHILADELPHIA--(BUSINESS WIRE)--Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, today announced the close of $38 million in total seed ...
The Hill

Cutting animal testing will jeopardize human health

The Food and Drug Administration and National Institutes of Health held a joint workshop July 7 on reducing animal testing in research, strikingly announcing that “NIH will no longer seek proposals ...
Forbes

This Startup Raised $38 Million To Fill One Of The Biggest Gaps In Drug Discovery

Khosla Ventures-backed Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials. Only about 10% of drugs in development ever make it to market.
Worcester Business Journal

Making sure AI works: UMass Chan’s new AI Assurance Lab tests developing healthcare tech, so it functions properly in the real world

By deploying and studying the impacts of AI tools across different healthcare providers and patient subgroups, the AI ...